TGA seeks input on benzocaine advisory statements
The Therapeutic Goods Administration (TGA) has requested comments from interested parties on the addition of a new advisory statement for labels of non-prescription medicines...
Choosing wisely: an insight into polypharmacy
In the second of a six-part series, we expand on the PSA Choosing Wisely recommendations, taking a closer look at polypharmacy.
The PSA’s Choosing Wisely...
Don’t forget about tuberculosis
TB is an infectious disease that has massive mortality globally; however, due to public health initiatives is mostly eradicated in Australia. Despite this, cases can still occur, and pharmacists should be aware of TB and its recommended treatment to ensure appropriate management.
Activate more pharmacist immunisers now
The thousands of community pharmacies assessed as suitable COVID-19 vaccination sites must be activated now.
Preventing harm: medicine safety in children
Medicine safety in children requires vigilance, clear communication and proactive intervention by pharmacists to prevent accidental poisonings.
Noradrenaline reuptake inhibitors and schizophrenia
Schizophrenia is a chronic illness characterised by a range of symptoms including positive and negative symptoms. Examples of positive symptoms include hallucinations, delusions, and...













